Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Atopic Dermatitis: Translating Guidelines into Practice --- The Rest of the Story
Description
The presentation discusses the complexities of atopic dermatitis (AD) management, highlighting the nuances of translating clinical guidelines into practical applications. The speaker underscores the importance of understanding how guidelines are formulated, the variability in the presentation of AD among different demographics, particularly in patients with skin of color, and the need for personalized treatments. Key topics include the limitations of recommendations regarding moisturizers and screening for comorbidities and the significance of recent developments in treatment options like biologics and JAK inhibitors. The discussion also covers the implications of these guidelines during pregnancy and the critical nature of patient education in managing AD effectively. The speaker emphasizes the diverse manifestations of AD and the variable impacts of treatments on different populations, suggesting the necessity for multidimensional approaches that consider genetic and environmental factors. Overall, the presentation advocates for improved education, awareness of potential side effects (like lymphoid reactions from dupilumab), and collaboration among healthcare providers to enhance the management of atopic dermatitis.
View moreConclusions
- Guidelines for atopic dermatitis support varied approaches informed by clinical evidence, patient experiences, and safety considerations.
- Preventative and responsive management strategies for atopic dermatitis must adapt to diverse demographic factors and disease presentations.
- Duplumab, while effective, has potential associations with lymphoid reactions that necessitate careful monitoring.
- Pediatric patients presenting with atopic dermatitis benefit from comprehensive care, involving interdisciplinary collaboration among dermatologists, allergists, and educational programs.
- The clinical manifestation and treatment of atopic dermatitis differ significantly across racial and ethnic groups, highlighting the need for culturally competent health care.
- Ongoing education and open dialogue with patients and families are crucial for effective atopic dermatitis management, particularly during pregnancy and in populations with skin of color.
- Further research is required to better understand the implications of socioeconomic status and environmental factors on the prevalence and management of atopic dermatitis.
- Eichenfield LF, Tom WL, Charrow A, et al. Diagnosis and Assessment of Atopic Dermatitis. J Am Acad Dermatol. 2014;70(3):338-51.
- Sidbury R, Tom WL, Bergman JN, et al. Phototherapy and Systemic Therapies for Atopic Dermatitis. J Am Acad Dermatol. 2014;70(3):350-68.
- Davis DM, Tucker T, Curry C, et al. Comorbidities of Atopic Dermatitis. J Am Acad Dermatol. 2022;86(6):1335-36.
- Sidbury R, Tom WL, et al. Topical Therapy for Atopic Dermatitis. J Am Acad Dermatol. 2023;89(1):e1-20.
- Davis DM, Gushi K, et al. Systemic Therapy for Atopic Dermatitis. J Am Acad Dermatol. 2024;90(2):e43-56.
- Munera-Campos M, et al. Atopic Dermatitis: Fertility, Pregnancy, and Treatment Perspectives. Am J Clin Dermatol. 2024;25(1):55-66.
- Quant VL, et al. Atopic dermatitis across shades of skin. Am J Clin Dermatol. 2023;24(5):731-51.
- Bagnini, et al. Longitudinal atopic dermatitis endotypes: an atopic march paradigm that includes Black children. J Allergy Clin Immunol.
- Takeshita J, et al. Atopic dermatitis and the atopic march: Considering racial and ethnic diversity in atopic dermatitis progression. J Allergy Clin Immunol. 2022.